Respiratory inhaler devices sales will expand through 2036, with manual inhalers at 91.0% of technology sales in 2026. The market was valued at USD 40.2 billion in 2025, is projected to reach USD 60.0 billion by 2036 and is forecast to record a 3.7% CAGR between 2026 and 2036.